WARNER-LAMBERT LIPITOR SHARE OF NEW STATIN SCRIPTS REACHES 24.2% IN LATE JUNE -- SCOTT-LEVIN; MERCK ZOCOR HITS $865 MIL. IN WORLDWIDE SALES FOR QUARTER
Executive Summary
Warner-Lambert's HMG-CoA reductase inhibitor Lipitor (atorvastatin) captured 24.2% of new prescriptions for statins for the week ending June 27, Scott-Levin reported.